Moneycontrol PRO

Plethico

Jump to
  • NSE to delist Kingfisher, Plethico Pharma, 16 others from May 30

  • Citi bullish on Aurobindo Pharma; says stock can re-rate

  • Stocks in news: Max India, Adani Ent, Biocon, Neyveli, MRPL

  • Aurobindo, Plethico rally post settlement over Natrol USA

  • Plethico Pharma consolidated Dec '14 sales at Rs 111.45 crore

  • Plethico Pharma consolidated Dec '13 sales at Rs 364.38 crore

  • Stocks in news: Cairn India, Elder Pharma, Ambuja, Bharti

  • BSE, NSE to shift scrips to restricted group from Nov 22

  • Plethico Pharma consolidated Sep '13 sales at Rs 470.69 crore

  • Here's how small cap stocks open on August 27

    Here's how small cap stocks open on August 27

  • Plethico Pharma consolidated Jun '13 sales at Rs 518.21 crore

    Plethico Pharmaceuticals has reported a sales turnover of Rs 518.21 crore and a net profit of Rs 44.40 crore for the quarter ended Jun '13

  • Plethico Pharma consolidated Mar '13 sales at Rs 490.50 crore

    Plethico Pharmaceuticals has reported a sales turnover of Rs 490.50 crore and a net profit of Rs 13.23 crore for the quarter ended Mar '13

  • Plethico Pharmaceuticals touches 5% upper circuit

    Plethico Pharmaceuticals is locked at 5 percent upper circuit on Tuesday after seeing a fall of 8.5 percent in previous two straight sessions.

  • Only buyers in Plethico Pharma, stock up 5%

    In the Plethico Pharmaceuticals there were pending buy orders of 17,878 shares, with no sellers available. At 14:30 hrs the share was quoting at Rs 221.90, up Rs 10.55, or 4.99 percent.

  • Only buyers in Plethico Pharma, shares up 5% for 4th day

    Plethico Pharmaceuticals is locked at 5 percent upper circuit for the fourth consecutive session on Monday.

  • Stocks in news: Plethico, RComm, Sintex, Gammon India, Idea

    Plethico Pharma | Reliance Communications | Deccan Chronicle Holdings | Sintex Industries | Gammon India | Gulf Oil | Den Networks | Kennametal India | NALCO | Bharti Airtel and Idea Cellular are stocks, which are in the news today.

  • Buy Plethico Pharma, JP Power, Shriram Transport: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Bull's eye: Buy Shriram Transport, Wockhardt; short HDIL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Hexaware Tech, Plethico Pharma, Jai Corp: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

  • Bull's eye: Buy Hexaware, AB Nuvo, Jai Corp; short Titan

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Plethico Pharma, Anant Raj; Sell Rel Comm: Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

  • Bull's eye: Buy PNB Gilts, Unitech, Century; short RComm

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy TVS Motor, Suzlon, CMC, short Infosys

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Plethico Pharma, Guj NRE, Suzlon Energy: SP Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

  • Bull's eye: Buy Suzlon Energy, SPIC, short SAIL, HDIL

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347